AIX-EN-PROVENCE, FRANCE--(Marketwired - Nov 12, 2015) - SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), the highly innovative ultrasound company, announced today that the clinical benefits of its ShearWave™ Elastography (SWE™) technology for non-invasive assessment of patients with chronic liver disease will be presented while attending the Liver Meeting® 2015. The meeting is taking place November 13th - 17th in San Francisco, CA. To date, over 60 liver disease-focused publications have demonstrated the reliability and effectiveness of SWE to assess the severity of liver fibrosis in several different clinical situations. In April 2015, results of a large scale...
↧